Tech Company Financing Transactions

Augmenix Funding Round

Augmenix, based in Waltham, secured $4.7 million in investment from private investors.

Transaction Overview

Company Name
Announced On
7/23/2009
Transaction Type
Venture Equity
Amount
$4,700,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
204 2nd Ave. Lower Level
Waltham, MA 02451
USA
Email Address
Overview
Augmenix's hydrogel technology improves outcomes in prostate radiation oncology and surgery. Learn more about the SpaceOAR system.
Profile
Augmenix LinkedIn Company Profile
Social Media
Augmenix Company Twitter Account
Company News
Augmenix News
Facebook
Augmenix on Facebook
YouTube
Augmenix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
John Pedersen
  John Pedersen LinkedIn Profile  John Pedersen Twitter Account  John Pedersen News  John Pedersen on Facebook
President
Pat Campbell
  Pat Campbell LinkedIn Profile  Pat Campbell Twitter Account  Pat Campbell News  Pat Campbell on Facebook
VP - Operations
Nick Svencer
  Nick Svencer LinkedIn Profile  Nick Svencer Twitter Account  Nick Svencer News  Nick Svencer on Facebook
VP - Regulatory Affairs
Noel Rolon
  Noel Rolon LinkedIn Profile  Noel Rolon Twitter Account  Noel Rolon News  Noel Rolon on Facebook
VP - Sales
Ken Knudson
  Ken Knudson LinkedIn Profile  Ken Knudson Twitter Account  Ken Knudson News  Ken Knudson on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/22/2009: Profectus BioSciences venture capital transaction
Next: 7/23/2009: ZocDoc venture capital transaction

 

Share this article

 


Where The Data Comes From

We record all VC transactions involving tech companies. VC investment data records reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary